Key Record Dates
ClinicalTrials.gov Identifier: | NCT03118466 |
---|---|
Brief Title: | Mitoxantrone, Etoposide, and Cytarabine (MEC) Plus Lenalidomide for Relapsed or Refractory Acute Myeloid Leukemia |
First Submitted : | March 30, 2017 |
First Submitted that Met QC Criteria : | April 17, 2017 |
First Posted : | April 18, 2017 |
Results First Submitted : | January 13, 2021 |
Results First Submitted that Met QC Criteria : | January 13, 2021 |
Results First Posted : | February 3, 2021 |
Last Update Submitted that Met QC Criteria : | January 13, 2021 |
Last Update Posted : | February 3, 2021 |